Carl Icahn takes stake in Bristol Myers: WSJ

(Reuters) - Activist investor Carl Icahn has taken a stake in Bristol-Myers Squibb Co (NYSE: BMY), the Wall Street Journal reported, citing people familiar with the matter.

Icahn sees the drugmaker as a possible takeover target, the Journal said. The size of the stake was unclear, the paper reported.

The company's shares spiked as much as 4.8 percent to $57.21 in late-afternoon trading on Tuesday.

Earlier in the day, Bristol-Myers said it added three directors to its board in an agreement with JANA Partners LLC, an activist investor holding less than 1 percent of the company's stock.

(Reporting by Divya Grover in Bengaluru; Editing by Sriraj Kalluvila)

---

Serious News for Serious Traders! Try StreetInsider.com Premium Free!

---

You May Also Be Interested In

• UBS Reiterates Buy Rating on Bristol-Myers Squibb Co. (BMY)
• Guggenheim Reiterates Buy Rating on Bristol-Myers Squibb Co. (BMY)
• Strong earthquake strikes central Peru, no damage reported